11,400 Shares in Perrigo Company (PRGO) Acquired by Yorktown Management & Research Co Inc
Yorktown Management & Research Co Inc bought a new position in shares of Perrigo Company (NYSE:PRGO) during the 3rd quarter, according to its most recent 13F filing with the SEC. The firm bought 11,400 shares of the company’s stock, valued at approximately $965,000.
A number of other hedge funds also recently made changes to their positions in the business. Vanguard Group Inc. raised its holdings in Perrigo by 2.1% during the 2nd quarter. Vanguard Group Inc. now owns 14,874,096 shares of the company’s stock worth $1,123,292,000 after buying an additional 299,328 shares during the period. Franklin Resources Inc. raised its holdings in Perrigo by 117.7% during the 2nd quarter. Franklin Resources Inc. now owns 8,109,742 shares of the company’s stock worth $612,448,000 after buying an additional 4,383,903 shares during the period. State Street Corp raised its holdings in Perrigo by 1.7% during the 2nd quarter. State Street Corp now owns 6,757,086 shares of the company’s stock worth $510,294,000 after buying an additional 112,287 shares during the period. Parnassus Investments CA raised its holdings in Perrigo by 7.1% during the 3rd quarter. Parnassus Investments CA now owns 2,257,000 shares of the company’s stock worth $191,055,000 after buying an additional 150,000 shares during the period. Finally, Goldman Sachs Group Inc. raised its holdings in Perrigo by 18.2% during the 2nd quarter. Goldman Sachs Group Inc. now owns 1,975,965 shares of the company’s stock worth $149,224,000 after buying an additional 304,950 shares during the period. Hedge funds and other institutional investors own 80.98% of the company’s stock.
Several analysts have commented on the stock. Cantor Fitzgerald set a $107.00 target price on shares of Perrigo and gave the stock a “buy” rating in a report on Wednesday, November 15th. Jefferies Group LLC reaffirmed a “hold” rating and set a $81.00 price target on shares of Perrigo in a research note on Friday, November 10th. Goldman Sachs Group, Inc. (The) raised shares of Perrigo from a “sell” rating to a “neutral” rating and raised their price target for the stock from $66.00 to $79.00 in a research note on Friday, August 11th. Stifel Nicolaus reaffirmed a “hold” rating on shares of Perrigo in a research note on Friday, August 11th. Finally, Royal Bank Of Canada raised their price target on shares of Perrigo from $60.00 to $64.00 and gave the stock an “underperform” rating in a research note on Friday, August 11th. One equities research analyst has rated the stock with a sell rating, eight have given a hold rating and eight have issued a buy rating to the stock. The company currently has a consensus rating of “Hold” and a consensus price target of $91.50.
In other Perrigo news, EVP Sharon Kochan sold 318 shares of Perrigo stock in a transaction dated Thursday, September 7th. The stock was sold at an average price of $81.36, for a total value of $25,872.48. Following the transaction, the executive vice president now owns 10,231 shares in the company, valued at $832,394.16. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, EVP Jeffrey Needham sold 3,595 shares of Perrigo stock in a transaction dated Tuesday, September 12th. The shares were sold at an average price of $89.49, for a total value of $321,716.55. Following the completion of the transaction, the executive vice president now owns 10,118 shares in the company, valued at approximately $905,459.82. The disclosure for this sale can be found here. In the last ninety days, insiders sold 6,242 shares of company stock valued at $532,091. 6.90% of the stock is owned by insiders.
Perrigo Company (NYSE PRGO) traded down $0.69 on Tuesday, hitting $85.20. The stock had a trading volume of 968,500 shares, compared to its average volume of 1,737,415. Perrigo Company has a 12 month low of $63.68 and a 12 month high of $91.73. The company has a quick ratio of 1.24, a current ratio of 1.72 and a debt-to-equity ratio of 0.54. The firm has a market capitalization of $12,100.00, a P/E ratio of 17.53, a P/E/G ratio of 1.83 and a beta of 0.59.
Perrigo (NYSE:PRGO) last posted its earnings results on Thursday, November 9th. The company reported $1.39 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.11 by $0.28. The company had revenue of $1.22 billion during the quarter, compared to the consensus estimate of $1.17 billion. Perrigo had a positive return on equity of 11.60% and a negative net margin of 26.28%. The company’s revenue was down 2.0% on a year-over-year basis. During the same quarter last year, the firm earned $1.65 earnings per share. sell-side analysts expect that Perrigo Company will post 4.88 EPS for the current year.
The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 19th. Investors of record on Friday, December 1st will be paid a $0.16 dividend. This represents a $0.64 dividend on an annualized basis and a yield of 0.75%. The ex-dividend date of this dividend is Thursday, November 30th. Perrigo’s dividend payout ratio (DPR) is presently -6.99%.
Perrigo Company plc is a global healthcare supplier that develops, manufactures and distributes over-the-counter (OTC) and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products, animal health, dietary supplements, active pharmaceutical ingredients (API), and medical diagnostic products, and Multiple Sclerosis drug Tysabri.
Want to see what other hedge funds are holding PRGO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Perrigo Company (NYSE:PRGO).
Receive News & Stock Ratings for Perrigo Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perrigo Company and related stocks with our FREE daily email newsletter.